<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02485054</url>
  </required_header>
  <id_info>
    <org_study_id>MOA_2014-32</org_study_id>
    <nct_id>NCT02485054</nct_id>
  </id_info>
  <brief_title>A Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances (VASCO)</brief_title>
  <acronym>VASCO</acronym>
  <official_title>Development and Validation of a Predictive Score for the Ischemic Etiology of a Transient Visual Disturbances</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The transient visual disturbances (TVD) are defined by a short abnormality of visual
      function. Their etiology may be ophthalmological, neurological non-ischemic or of ischemic
      origin.

      The difficulty is to recognize an ischemic mechanism which imposes emergency cares.

      A clinical score could help the clinician to recognize the etiology of the TVD .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Etiology, ischemic or not, of the initial transient visual disturbance</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of new visual transient ischemic attacks during the 3 months of follow-up</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of visual ischemic strokes during the 3 months of follow-up</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of transient ischemic attacks, visual or not visual, during the 3 months of follow-up</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of ischemic strokes, visual or not visual, during the 3 months of follow-up</measure>
    <time_frame>3 months</time_frame>
    <description>Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography and a new evaluation after 3 months.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Vision Disorders</condition>
  <arm_group>
    <arm_group_label>Eligible patients</arm_group_label>
    <description>Adults having had a transient visual disturbance during the last 8 days, except a diplopia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Clinical, ophthalmological and neurological evaluation</intervention_name>
    <description>Clinical : questionnaire about the symptoms and about the vascular risk factors Cerebral MRI, MRI angiography of the supra-aortic trunks, ECG, Holter, transthoracic echocardiography, blood count, erythrocytes sedimentation rate, C reactive protein, visual field, optical coherence tomography, retinography</description>
    <arm_group_label>Eligible patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults having had a transient visual disturbance during the last 8 days and seen at the
        fondation ophtalmologique Adolphe de Rothschild
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Transient visual disturbances (i.e. less than 24 hours) during the last 8 days

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hôpital Bichat</name>
      <address>
        <city>Paris</city>
        <zip>75018</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre AMARENCO, PhD</last_name>
      <email>pierre.amarenco@bch.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Pierre AMARENCO, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondation ophtalmologique Adolphe de Rothschild</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mickaël Obadia, MD</last_name>
      <phone>0033148036431</phone>
      <email>mobadia@for.paris</email>
    </contact>
    <contact_backup>
      <last_name>01 48 03 64 31 Lamirel, MD</last_name>
      <phone>0033148036431</phone>
      <email>clamirel@for.paris</email>
    </contact_backup>
    <investigator>
      <last_name>Mickaël Obadia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 18, 2015</study_first_submitted>
  <study_first_submitted_qc>June 25, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2015</study_first_posted>
  <last_update_submitted>February 8, 2018</last_update_submitted>
  <last_update_submitted_qc>February 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vision Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

